Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Accumulated Depreciation & Amortization (2017 - 2025)

Organogenesis Holdings has reported Accumulated Depreciation & Amortization over the past 9 years, most recently at $61.4 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 20.18% year-over-year to $61.4 million; the TTM value through Dec 2025 reached $61.4 million, up 20.18%, while the annual FY2025 figure was $61.4 million, 20.18% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $61.4 million at Organogenesis Holdings, up from $56.6 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $61.4 million in Q4 2025 and troughed at -$76.3 million in Q2 2024.
  • A 5-year average of $20.9 million and a median of $15.2 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 610.45% in 2023 and later tumbled 1172.89% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $10.3 million in 2021, then plummeted by 126.92% to -$2.8 million in 2022, then skyrocketed by 610.45% to $14.1 million in 2023, then surged by 261.65% to $51.1 million in 2024, then rose by 20.18% to $61.4 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ORGO at $61.4 million in Q4 2025, $56.6 million in Q3 2025, and $56.2 million in Q2 2025.